Enanta Pharmaceuticals | ENTA - Dividendenrendite





Dy Veränderung Datum
AbbVie 3.1 0.19 2026-03
Amgen 2.78 0.17 2026-03
Anika Therapeutics 0 0 2025-03
AstraZeneca USD 1.18 0.56 2026-03
BioCryst Pharmaceuticals 0 0 2025-03
Bristol-Myers Squibb 4.12 3.9 2026-03
Enanta Pharmaceuticals 0 0 2025-03
Gilead Sciences 2.58 0.25 2025-12
GlaxoSmithKline 0.82 3.75 2026-03
Heron Therapeutics 0 0 2025-03
J&J 2.16 0.34 2026-03
Karyopharm Therapeutics 0 0 2025-03
Merck 2.76 0.36 2026-03
Novartis USD 3.33 0.29 2026-03
Pfizer 6.91 0.33 2025-12
Roche Holding 2.96 0.8 2025-12